Multiuser Image-guided small animal X-ray Platform.
Multiuser Image-guided small animal X-ray Platform.
批准号:
9274114
负责人:
MOHAN NATARAJAN
金额:
$57.62万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2019-03-31
关键词:
Advisory CommitteesAir PressureAnestheticsAnimalsBiologicalCellsCore FacilityDepartment of DefenseEquipmentFDA approvedFailureFundingFutureHeadImmobilizationIncomeJournalsLaboratoriesLifeManufacturer NameMusNaturePerformancePhysiciansPositioning AttributeProductivityPublicationsRadiation exposureRadioactiveResearch PersonnelResearch Project GrantsRoentgen RaysRunningSafetySamplingSchoolsScienceScientistSeminalSourceSystemTechnical ExpertiseTherapeutic StudiesTimeTransgenic OrganismsUnited States Department of Veterans AffairsUnited States National Institutes of Healthanticancer researchbiological researchcancer therapydesignimage guidedirradiationmedical schoolsoperationresearch studytargeted delivery
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We are requesting funds to purchase a SARRP image-guided x-ray platform in order to continually support a
total of 26 research projects. Among the currently funded projects that requires the use of the irradiator, nine of
them are NIH RO1, one PO1 and one U-42 projects. Additionally, one funded FDA approved phase1/2 study and
four NIH RO1 projects that are likely to get funded (currently under council review) proposed to use the
irradiator. Apart from that, four other federally funded projects (US Department of Defense, Veteran
Administration) and six state- or institutional-funded project depend on the irradiator use. The track record and
productivity out of the current irradiator use is significant with seminal publications including the journals
Nature, Mol. Cell Biol., J Biol. Chem., PNAS, and Cancer Research. As an added benefit, the irradiation facility
is integrated with other institutional core facilities including institutional transgenic core platform. Currently the
investigators perform their radiation exposures for biological samples in a Gamma Cell-40 irradiator which has
been in use since 1980. As of March 2010, the manufacturer proclaimed this 35-year old 137Cs source irradiator
an end-of-useful lifecycle and informed that the company can no longer guarantee replacement parts on this old
unit. It periodically shows a faulty door-lock system and air pressure resulting in inappropriate positioning of
the exposures heads or over exposure due to failure in unlocking the door. When safety system kicks-in, due to
unsecured door locks, sometimes, system fails to switch on. In addition, since this decades-old equipment has
no provision for partial body irradiation or targeted delivery, it is unable to meet the requirements of several
current and newly approaching research studies. Unlike the old irradiator SARRP 200 can be used for animals
other than mice. Built-in immobilization system allows the users to expose the animals under anesthetic
condition which is not possible with the current irradiator. The SARRP image guided irradiator platform has no
radioactive source and is designed specifically as Cs replacement for biological research. Additionally, SARRP
has several advantageous over its principal commercial competitors. The SARRP 200 irradiation system is
chosen for its performance more suited for the current and future users, wide use in several laboratories, safety,
durability, self-shielding, and its useful life time. We have a carefully constituted an internal advisory committee
for a productive operation of the irradiator for an extended period of time. With a strong institutional support
and technical expertise by running the irradiator for the past several years we are confident that we can diligently
operate the irradiator and support the current projects and meet the challenges/ requirements of incoming
studies in future. Both physicians from the Medical School and the NCI designated Cancer Therapy Research
Center (CTRC), and translational/basic scientists with multiple NIH projects from UTHSCSA Graduate School
of Biomedical Sciences can take full advantage of this equipment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENHANCED APOPTOSIS BY TARGETING PROTEIN REDOX STATUS
-
批准号:7318324
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2005
-
负责人:MOHAN NATARAJAN
-
依托单位:
ENHANCED APOPTOSIS BY TARGETING PROTEIN REDOX STATUS
-
批准号:7048278
-
项目类别:
-
资助金额:$18.79万
-
财政年份:2005
-
负责人:MOHAN NATARAJAN
-
依托单位:
ENHANCED APOPTOSIS BY TARGETING PROTEIN REDOX STATUS
-
批准号:7157589
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2005
-
负责人:MOHAN NATARAJAN
-
依托单位:
ENHANCED APOPTOSIS BY TARGETING PROTEIN REDOX STATUS
-
批准号:7533486
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2005
-
负责人:MOHAN NATARAJAN
-
依托单位:
海外基金